About PVH Staff

This author has not yet filled in any details.
So far PVH Staff has created 268 blog entries.

Precision Medicine Group Acquires Stern Investor Relations, Inc.

2020-02-18T15:39:10+00:00News|

Strengthens Precision’s Position as Leading Partner to Pharmaceutical and Life Sciences Companies at All Life Cycle Stages

Bethesda, MD – December 17, 2018 – Precision Medicine Group, LLC. (Precision) today announced it has acquired Stern Investor Relations, Inc. (Stern IR), a leading investor relations firm for entrepreneurial biotechnology and healthcare companies. With this acquisition, Precision significantly expands its capabilities to include a complete range of strategic communication services aimed at facilitating capital formation and enhancing client visibility and productive interactions with the financial community. Stern IR supports more than 70 companies in the entrepreneurial biotechnology and healthcare sectors, and its core competencies include creation of investor relations strategy aimed at lowering the cost of capital, positioning and messaging development, relationship building with the financial community, and seamless tactical execution. (more…)

Read More

How Prescribers Affect Launch Success

2020-02-18T15:39:10+00:00Thought Leadership|

In a featured article for PM360, Precision’s Ross Maclean and Phil Cyr identify three themes and eight interrelated factors which, if overlooked, can negatively impact a launch. In short, prescribers remain Very Important People in a launch, facing challenges around Vulnerability, Incentives, and Personalization.

(more…)

Read More

Precision Xtract Taps Industry Leader Zac Stillerman as New President & General Manager

2020-02-18T15:39:10+00:00News|

 

VETERAN STRATEGIST CHOSEN TO LEAD INNOVATIVE HEALTH ECONOMICS,
MARKET ACCESS, AND PAYER ANALYTICS CONSULTANCY  

Bethesda, MD – November 7, 2018 – Precision Xtract, part of Precision Value & Health, today announced Zac Stillerman, acclaimed healthcare industry operator and strategist, as new president and general manager. Responsible for leading Precision Xtract through its next phase of growth, Stillerman has a proven ability to translate vision and strategy into dynamic collaboration and first-class execution. He joins Precision Xtract at a time of growing demand from innovative life sciences companies for essential consulting activities, including health economic outcomes research, value demonstration, pricing and market access, and commercialization.

(more…)

Read More

New FDA HCEI and PIE Guidelines Released: Are You Prepared? Sign up for our Free, Live Webinar Today!

2020-02-18T15:39:10+00:00Events, News|

 

On Wednesday, September 26th at 10:00am PDT/1:00pm EDT please join us for a special, live webinar:

Navigating the FDA’s Final Guidance on HCEI and PIE:
Value Communication That Works 

Presented by:

Ross Maclean, MD, PhD
Vice President,
Head of Medical Affairs		 Ami Gopalan, PharmD, MBA
Vice President, Director,
Payer Access Solutions

(more…)

Read More

HCEI and PIE: Is it time for pharma to be proactive in the argument over cost-effectiveness?

2020-02-18T15:39:11+00:00Thought Leadership|

 

The FDA and the US Department of Health and Human Services published final guidance on the presentation of health care economic information (HCEI) and preapproval information exchange (PIE). This is a new opportunity for manufacturers to engage with payers around cost-effectiveness. Precision’s Jeremy Schafer views it from the manufacturer’s perspective in his article for KNect365. (more…)

Read More
Load More Posts

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

© Precision Medicine Group, LLC. All Rights Reserved.